Effects of Ginkgo biloba on cerebral blood flow assessed by quantitative MR perfusion imaging: a pilot study
A pilot study investigated the effects of Ginkgo biloba extract (EGb) on cerebral blood flow (CBF) in nine healthy elderly men, using dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSC-MRI). After four weeks of EGb supplementation (60 mg twice daily), results indicated a mild increase in CBF, particularly in the left parietal–occipital white matter, suggesting that […]
Ginkgo biloba in Neuropsychiatric Disorders: From Ancient Tradition to Modern-Day Medicine
A review of studies looked at how well Ginkgo biloba works for brain-related conditions like dementia and schizophrenia. The findings showed that it helped improve memory and daily activities in people with dementia and reduced some symptoms in schizophrenia, but it didn’t help with all symptoms or conditions like depression, anxiety, ADHD, or addiction.
Ginkgo biloba in the Aging Process
The narrative review examines the effects of Ginkgo biloba (GB) on age-related conditions such as neurodegenerative diseases, cardiovascular disease (CVD), and cancer. The review highlights GB’s potential benefits, including improvements in memory, cognition, and quality of life, as well as reductions in oxidative stress, inflammation, and metabolic risk factors, suggesting its usefulness in preventing and […]
Advances in the Studies of Ginkgo Biloba Leaves Extract on Aging-Related Diseases
The review article examines the pharmacological mechanisms and clinical applications of Ginkgo biloba extract (EGb) in treating degenerative disorders. It highlights EGb’s antioxidant properties, its role in preventing mitochondrial dysfunction, and its effects on apoptosis, contributing to neuroprotection, cardiovascular health, and potential anticancer benefits.
Ginkgo biloba extract improves cognitive function and increases neurogenesis by reducing Aβ pathology in 5×FAD mice
The study investigates the effects of Ginkgo biloba extract (EGb 761) on cognitive deficits in a mouse model of Alzheimer’s disease. The findings revealed that EGb 761 administration enhanced memory performance, increased the proliferation of new neurons in the hippocampus, and reduced amyloid-beta (Aβ) accumulation, suggesting its potential therapeutic role in mitigating Alzheimer’s-related cognitive decline.